Back to Market Feed

Product Information

EDARBYCLOR 40-12.5 MG TABLET is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $8.4957 per EA under NDC 60631041230. Its NADAC has been published 616 times since Nov 5, 2014.

FDA first approved this application on Dec 20, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EDARBYCLOR 40-12.5 MG TABLET

Azilsartan kamedoxomil and chlorthalidone
$8.4957per EA

Strength

40; 12.5 mg/1; mg/1

NDC

60631041230

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA202331

FDA Approved

12/20/2011

TE Code

AB

On Market Since

2/1/2013

Pharmacological Classes

Angiotensin 2 Receptor Blocker
Angiotensin 2 Type 1 Receptor Antagonists
Decreased Blood Pressure
Increased Diuresis
Thiazide-like Diuretic

Price Statistics

The NADAC for EDARBYCLOR 40-12.5 MG TABLET has been published 616 times since Nov 5, 2014, and over the history we have for it it has risen 104.9%. The table below summarizes its recorded NADAC range and movement.

Current price$8.4957 per EA
All-time high$8.5076 (Jun 11, 2025)
All-time low$4.1185 (Nov 19, 2014)
52-week high$8.5054
52-week low$8.4940
Median price$6.4440
Average price$6.5273
Largest weekly change+10.0% (Feb 11, 2015)
Weeks tracked616
Tracking sinceNov 5, 2014

Price History

1W

-0.0%

1M

-0.0%

3M

+0.0%

6M

-0.1%

1Y

-0.1%

3Y

+19.9%

5Y

+27.8%

All

+104.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Azilsartan kamedoxomil and chlorthalidone market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

DIURIL 250 MG/5 ML ORAL SUSP
Brand
65649031112•Salix Pharmaceuticals Inc.
$0.2787
per ML
HEMICLOR 12.5 MG TABLET
Brand
50742028530•Ingenus Pharmaceuticals LLC
$0.9570
per EA
HEMICLOR 12.5 MG TABLET
Brand
50742028590•Ingenus Pharmaceuticals LLC
$0.9570
per EA
COZAAR 25 MG TABLET
Brand
78206012101•Organon LLC
$3.3500
per EA
THALITONE 15 MG TABLET
Brand
70199001730•Casper Pharma LLC
$3.5373
per EA
INZIRQO 10 MG/ML ORAL SUSP
Brand
70954052210•ANI Pharmaceuticals, Inc.
$4.4572
per ML
MICARDIS HCT 80-25 MG TABLET
Brand
00597004237•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4768
per EA
EPANED 1 MG/ML ORAL SOLUTION
Brand
52652400101•Azurity Pharmaceuticals Inc.
$4.4785
per ML
MICARDIS HCT 80-12.5 MG TABLET
Brand
00597004437•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4802
per EA
MICARDIS 80 MG TABLET
Brand
00597004137•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4823
per EA

Frequently asked questions

What is the NADAC price of EDARBYCLOR 40-12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EDARBYCLOR 40-12.5 MG TABLET, manufactured by Azurity Pharmaceuticals Inc., is $8.4957 per EA (NDC 60631041230), effective Aug 19, 2026.

How has the price of EDARBYCLOR 40-12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for EDARBYCLOR 40-12.5 MG TABLET has risen 104.9%. It has been tracked across 616 weekly CMS publications since Nov 5, 2014.

What are the highest and lowest recorded NADAC prices for EDARBYCLOR 40-12.5 MG TABLET?

Since Nov 5, 2014, the NADAC for EDARBYCLOR 40-12.5 MG TABLET has ranged from a low of $4.1185 (Nov 19, 2014) to a high of $8.5076 (Jun 11, 2025), with a median of $6.4440 per EA.

Are there cheaper alternatives to EDARBYCLOR 40-12.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of EDARBYCLOR 40-12.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures EDARBYCLOR 40-12.5 MG TABLET?

EDARBYCLOR 40-12.5 MG TABLET (NDC 60631041230) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.